Efatutazone Terminated Phase 1 Trials for Tumors, Solid / Multiple Myeloma (MM) / Malignant Lymphomas Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01504490Phase I Study of CS-7017 and Bexarotene